The recent US healthcare bill is a great help to India’s pharmaceutical industry, which is focused on the generic drug market and contract manufacturing.
India's pharmaceutical companies enjoy the advantage of having access to a good talent pool at affordable costs and they boast of having the largest number of US Food and Drug Administration (FDA) approved production facilities outside the US.
As the industry matures, the growth has to come not only through capacity expansion but also through productivity improvements and the pursuit of operational excellence to satisfy regulatory authorities about compliance to standards, good manufacturing practices and electronic record keeping.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment